课题基金 / 基金详情

GDNF FOR THE TREATMENT OF PARKINSON'S DISEASE

GDNF FOR THE TREATMENT OF PARKINSON'S DISEASE
GDNF 用于治疗帕金森病
批准号：
6116964
负责人：
JOHN G NUTT
金额：
$3.13万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6116964
关键词：
Parkinson's disease antiparkinson drugs clinical research clinical trials drug screening /evaluation human subject human therapy evaluation intravenous administration mental disorder chemotherapy neurotrophic factors

项目摘要

项目成果

JOHN G NUTT的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
GDNF is a neurotrophic factor which has been shown to have antiparkinson effects in monkeys with parkinsonism. This study will examine the effects of GDNF administered intraventricularly in patients with Parkinson's disease using a double-blind, placebo-controlled study design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
METHYLPHENIDATE IN PARKINSON'S DISEASE
Methylphenidate in PD
DBS , Deep Brain Stimulation and Levodopa
Levodopa Pharmacokinetics and Pharmacodynamics